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ABSTRACT 
 
The Effects of Leptin Antagonist on Hypothalamic Neuropeptide Y Circuitry in Infantile 
Male Lambs. (May 2012) 
 
Michelle Bedenbaugh 
Department of Animal Science 
Texas A&M University 
 
Research Advisor: Dr. Marcel Amstalden 
Department of Animal Science 
 
It is proposed that leptin signaling during infantile development is critical for structural 
organization of hypothalamic circuitry involved in the control of food intake and energy 
expenditure. The present study tested the hypothesis that disruption of leptin signaling 
alters the neuropeptide Y (NPY) circuitry in the hypothalamus of infantile lambs. 
Twelve neonatal Dorset X Finn male lambs were assigned randomly to one of three 
experimental groups (n = 4/group): 1) Early Antagonist (EA), 2) Late Antagonist (LA) 
and 3) Control (CN).  Lambs in the EA group were injected i.v. with 0.23 mg/Kg0.75 of 
pegylated super ovine leptin antagonist (PEG-SOLA) twice daily from birth to postnatal 
Day 14. Concurrently, lambs in the LA and CN groups were injected with an equivalent 
volume of physiological saline. From postnatal Day 30 to 36, lambs in the LA group 
were injected i.v. with 0.46 mg/Kg0.75 of PEG-SOLA twice daily, while lambs in the CN 
and EA groups were injected with physiological saline. On postnatal Day 40, lambs were 
euthanized, and a block of tissue containing the hypothalamus was collected and 
processed for detection of NPY by immunocytochemistry. The distribution of NPY 
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fibers in tissue sections was observed using bright-field microscopy and images 
representing various regions of the hypothalamus were captured using a 10X objective. 
The area covered by NPY-immunoreactive fibers was determined in regions of interest 
to represent the density of NPY fibers within each hypothalamic area analyzed. The 
mean density of NPY fibers did not differ significantly among the three treatment groups 
in any of the areas studied; however, the area covered by NPY fibers in the 
paraventricular nucleus tended to be greater in lambs treated with leptin antagonist early 
during the infantile period than in the control and late antagonist groups. Results of this 
study indicate that short-term disruption of leptin signaling during the infantile period 
does not clearly alter the density of NPY fibers in the hypothalamus of lambs. Additional 
studies should investigate whether other functional aspects of the NPY system (e.g., 
NPY synthesis and projections to target cells) are disrupted by leptin antagonist. 
  v 
DEDICATION 
 
This manuscript is dedicated to my parents, Stephen and Christine Bedenbaugh, and my 
brother, Robby Bedenbaugh, who have always been there to offer advice and support.   
  vi 
ACKNOWLEDGMENTS 
 
The author expresses her sincere appreciation to Dr. Marcel Amstalden for his 
continuous support and advice throughout the process of completing this thesis. Thanks 
also to Sarah Sharpton and Bruna Alves for always offering advice and helping out with 
lab work. Special thanks to Dr. Yves Boisclair and Jose Ramos-Nieves, Cornell 
University, for their collaborative efforts in designing and conducting the animal-related 
experiments and tissue collection, and to Dr. Arieh Gertler, The Hebrew University of 
Jerusalem, for providing the leptin antagonist. 
 
 
 
 
 
 
 
 
 
 
 
 
  
  vii 
TABLE OF CONTENTS 
  Page 
ABSTRACT.......................................................................................................................iii 
DEDICATION .................................................................................................................... v 
ACKNOWLEDGMENTS.................................................................................................. vi 
TABLE OF CONTENTS..................................................................................................vii 
LIST OF FIGURES..........................................................................................................viii 
LIST OF TABLES ............................................................................................................. ix 
CHAPTER 
 I INTRODUCTION....................................................................................... 1 
 II MATERIALS AND METHODS................................................................ 3 
  Animals and experimental procedures ........................................................ 3 
  Tissue processing and immunocytochemistry............................................. 5 
  Morphological analysis ............................................................................... 6 
  Density of NPY fibers ................................................................................. 6 
  Statistical analysis ....................................................................................... 7 
 
 III RESULTS.................................................................................................... 8 
Distribution of immunoreactive NPY fibers in the POA and 
hypothalamus...............................................................................................8  
Density of NPY-immunoreactive fibers in the POA and hypothalamus .. 11    
 IV DISCUSSION AND CONCLUSIONS..................................................... 13 
REFERENCES.................................................................................................................. 17 
CONTACT INFORMATION........................................................................................... 20 
 
  viii 
LIST OF FIGURES 
 
FIGURE Page 
 1 Low power photomicrograph illustrating NPY-immunoreactive fibers in the 
paraventricular nucleus (PVN; A) and arcuate nucleus (ARC; B).  ....................10 
  
  ix 
LIST OF TABLES  
 
TABLE Page 
1 Distribution and density of NPY-immunoreactive fibers in the preoptic area  
and hypothalamus of 40 day-old male lambs ........................................................9 
2 Mean proportion of area covered by NPY-immunoreactive fibers in the POA  
and hypothalamus of 40-day old male lambs (n = 4/group) treated with saline 
(CN), leptin antagonist between birth and PD 14 (EA), and leptin antagonist 
between PD 30 and 35 (LA).................................................................................12 
 
  1 
CHAPTER I 
INTRODUCTION 
 
The recent increased prevalence of childhood obesity in the United States has been a 
major health concern.  Currently, approximately 33% of children between the ages of 6 
and 11 are considered overweight or obese [1], and becoming overweight at early ages 
predisposes children to adulthood obesity, diabetes and cardiovascular disease.  
Therefore, understanding the mechanisms by which excessive weight gain during the 
juvenile period predisposes individuals to disease later in life may help in the design of 
novel strategies to improve human health and well-being. 
 
Increased adiposity has been associated with increased circulating concentrations of the 
adipocyte-derived hormone leptin [2, 3, 4].  Leptin administration decreases food intake 
and increases energy expenditure [5, 6].  A major pathway by which leptin seems to 
regulate metabolic function involves neuropeptide Y (NPY) neurons located in the 
arcuate nucleus (ARC) of the hypothalamus. Feed restriction increases NPY expression 
in the ARC [7] and NPY stimulates food intake [8, 9].  Administration of leptin 
decreases expression of the NPY gene in the ARC [10], likely by direct actions on NPY 
neurons [11].  Leptin may also exert its effects by regulating structural components of 
neuronal circuitries within the hypothalamus.  Circulating concentrations of leptin  
_______________ 
This thesis follows the style of Domestic Animal Endocrinology. 
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increase during the early postnatal period in rodents [12], and there is evidence that this 
elevation in leptin plays a role in regulating the development of neural projections within 
the ARC involved in the control of food intake [13].  There is also evidence for early 
postnatal increases in circulating leptin in sheep [14].  However, maternal obesity during 
gestation, a condition that predisposes offspring to increased appetite and weight gain 
[15], ablates the early postnatal increase in circulating leptin [16].  In addition, postnatal 
nutrition influences concentrations of leptin in circulation [17].  It is proposed that 
during the infantile and juvenile periods, leptin promotes structural organization of 
hypothalamic circuitries important for programming neuroendocrine functions in lambs.  
Therefore, we hypothesized that disruption of the leptin signaling alters the structural 
organization of the NPY circuitry in the hypothalamus of infantile lambs.  To test this 
hypothesis, an antagonist of leptin was administered to neonatal and infantile lambs and 
neuronal projections containing NPY were investigated in hypothalamic regions known 
to regulate various physiological functions, including the control of metabolism and food 
intake.   
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CHAPTER II 
 
MATERIALS AND METHODS 
 
Animals and experimental procedures 
 All animal-related procedures were performed at Cornell University with the approval 
of the Cornell University Institutional Animal Care and Use Committee. Neonatal 
Dorset X Finn male lambs were used for this study. At birth, lambs were retrieved before 
first suckling, towel-dried, weighed and fed pooled cow colostrum to an amount 
equivalent to 10% of their birth weight within the first 30 minutes of life.  Only lambs 
weighing approximately 3.5 to 4 kg at birth were used.  The lambs were then transferred 
to a controlled-environment facility that was maintained at a temperature of 25°C and a 
photoperiod of 12/12 hours of light/dark cycles.  Lambs were housed individually in 
stainless steel cages (75cm width x 80cm length x 80cm height) for 17 days.  After this 
initial period, lambs were then transferred to pens where they were housed until the 
completion of the experiment on postnatal day (PD) 40.  During the experimental period, 
lambs were offered ad libitum access to a milk replacer prepared with 20% wt/wt (18.9 
dry matter [DM] wt/wt) milk powder containing 28% fat and 30% protein on a DM 
basis. Milk replacer was offered cold (4°C) at 8 am in clean plastic containers with latex 
nipple units, and it was allowed to equilibrate to room temperature. Buckets were re-
filled at 4 pm and 8 pm when necessary. 
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Lambs were assigned randomly to one of the three treatment groups; 1) Early Antagonist 
(EA; n = 4): lambs were injected with pegylated super ovine leptin antagonist (PEG-
SOLA; 0.23 mg/kg0.75) intravenously (i.v.) twice a day from birth to PD 14 and an 
equivalent volume of physiological saline from PD 15 to 36; 2) Late antagonist (LA; n = 
4): lambs were injected with physiological saline i.v., twice a day from birth to PD 29 
and with PEG-SOLA (0.46 mg/kg0.75) from PD 30 to 35; and 3) Control (CN; n = 4): 
lambs were injected with physiological saline i.v. twice a day from birth to PD 36. At 
PD 40, lambs were administered a dose of 10,000 U heparin i.v. and anaesthetized with 
an overdose of propofol (8mg/kg BW, i.v.) 5 minutes later. After confirmation that 
animals were deeply anesthetized (respiratory depression and loss of eye-lid reflexes), 
lambs were decapitated.  The heads were perfused via both carotid arteries with 
heparinized saline (10U/ml) for 5 minutes and then with 3 liters of 4% paraformaldehyde 
in 0.1 M phosphate buffer (PB; pH 7.3) containing 0.1% sodium nitrite.  The cranium 
was dissected, and the brain was removed. A block of tissue containing the septum, the 
preoptic area and the hypothalamus was dissected.  The tissue block was stored in 4% 
paraformaldehyde at 4° C overnight and then transferred to a 0.1 M PB solution 
containing 30% sucrose until the tissue had sunk, indicating sucrose infiltration.  Tissue 
blocks were shipped to Texas A&M University for further processing. 
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Tissue processing and immunocytochemistry  
Tissue blocks were cut in coronal sections of 50 µm using a freezing microtome.  The 
sections were then stored at -20 ºC in a cryopreservative solution until processed for 
immunocytochemistry.  One series of sections 200 µm apart was used for this study. 
Immunocytochemistry for detection of NPY was performed at room temperature with 
gentle shaking.  Free-floating tissue sections were washed in 0.1 M PB containing 0.9% 
NaCl (phosphate-buffered saline; PBS) for at least 4 hours to aid in removal of 
cryopreservative.  After this initial washing, the sections were washed in PBS four times 
for 5 minutes to ensure that the cryopreservative had been removed.  The sections were 
then incubated in PBS containing 1% hydrogen peroxide for 10 minutes to remove 
endogenous peroxidase activity.  After further washing, the sections were incubated in a 
solution of PBS containing 0.4% Triton-X100 (PBSTX) and 4% normal goat serum 
(NGS) for at least 1 hour.  The sections were then incubated in a solution containing 
rabbit anti-NPY antiserum (1:250,000 dilution; Sigma Aldrich) in PBSTX, and 4% NGS 
for 16 hours.  After incubation with the primary antibody, the sections were washed and 
then incubated in a solution containing biotinylated goat anti-rabbit IgG (1:400 dilution; 
Vector Laboratories), PBSTX, and 4% NGS for 1 hour.  The sections were washed and 
then incubated in a solution containing streptavidin horseradish-peroxidase conjugate 
(Vectastin Elite ABC, Vector Laboratories; 1:600 dilution) for 1 hour.  Sections were 
washed and incubated in a solution containing 3,3-diaminobenzidine (DAB; 0.2 mg/ml) 
with hydrogen peroxide (0.012%; Sigma) in PBS for 10 minutes.  The sections were 
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washed, mounted on slides and covered with coverslip using DPX (VWR International) 
for analysis.     
 
Morphological analysis 
Neuropeptide Y-immunoreactive fibers were identified by microscopy and visualized by 
the presence of dark-brown DAB staining using a dark and bright field microscope 
(Nikon 80i Eclipse; Nikon Inc., Melville, NY, USA).  The location of NPY fiber 
immunoreactivity was investigated in a rostral to caudal continuum from the septum and 
preoptic regions through the hypothalamus.  Anatomical distribution of NPY fibers 
within these regions were in accordance to those described previously for the sheep brain 
[18, 19] and included the preoptic area (POA), the periventricular nucleus (PeV), the 
paraventricular nucleus (PVN), the arcuate nucleus (ARC), the ventral medial 
hypothalamus (VMH), the dorsal medial hypothalamus (DMH), the premammillary 
ventral nucleus (PMV), the median eminence (ME), and the lateral hypothalamus (LH).   
 
Density of NPY fibers 
For each region of the brain examined, four sections within the POA (including two 
sections at the level of the organum vasculosum of the lamina terminalis [OVLT]), three 
through the PeV, four through the PVN, two through the rostral ARC, four through the 
medial ARC, two through the caudal ARC, three through the VMH, three through the 
DMH, three through the PMV, three through the ME, and three through the LH were 
selected.  Sections were selected to represent comparable levels through all areas 
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examined from each lamb.  Images of each region were captured using a 10X objective 
and a digital camera (DS-Qi1; Nikon) attached to the microscope.  The density of fibers 
was determined by establishing the area covered by immunoreactive product in a region 
of interest (ROI) within each image collected.  The NIS-Elements software (Nikon) was 
used for image analysis.  A threshold signal was established and applied to all images 
before the number of pixels was determined in the standardized ROI.  The number of 
pixels associated with NPY immunoreactivity within each ROI was recorded and 
transformed to proportion of the total area of the ROI to represent the density of NPY 
fibers in the various areas analyzed. 
 
Statistical analysis 
The proportional area covered by NPY fibers in each region was normalized using the 
arcsine-square root transformation and analyzed by Analysis of Variance (ANOVA) 
using the general linear models (GLM) procedure of the Statistical Analysis System 
(SAS).  Treatment was used as source of variation. 
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CHAPTER III 
RESULTS 
 
Distribution of immunoreactive NPY fibers in the POA and hypothalamus 
Immunoreactive NPY fibers were observed to be widely distributed from the septum and 
POA, including at the level of the OVLT, to the caudal portions of the hypothalamus at 
PD 40 in male lambs.  Overall, the highest density of fibers was found in the ME, with 
fibers extending towards the external (secretory) zone.  A high density of fibers was also 
observed in the ARC and PVN (Fig. 1).  In the more rostral aspect of the PVN, NPY 
fibers were first present ventrally projecting along the third ventricle.  In the more caudal 
portions of the PVN, the fibers were distributed throughout the nucleus, forming a 
characteristic wing-shape adjacent to the third ventricle (Fig. 1A). Within the POA, 
PMV, VMH, and PeV, the density of NPY fibers was moderate.  In the more rostral 
sections of the POA, the majority of fibers were clustered around the OVLT.  In the 
more caudal sections of the POA, fibers were concentrated at the base of the brain, 
adjacent to the third ventricle.  Similar to the distribution in the PVN, NPY fibers in the 
PeV were observed distributed throughout the extent of and adjacent to the third 
ventricle.  NPY fibers in the DMH and LH were observed only sparsely distributed.  
Table 1 summarizes the relative distribution of NPY fibers in the POA and 
hypothalamus. 
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Table 1 
Distribution and density of NPY-immunoreactive fibers in the preoptic area and 
hypothalamus of 40 day-old male lambs. 
Area Fiber Densitya 
ARC ++++ 
DMH + 
LH + 
ME ++++ 
PeV ++ 
PMV ++ 
POA ++ 
PVN +++ 
VMH ++ 
a ++++, dense; +++, high; ++, moderate; +, low. 
 
 
 
Figure 1.  Low power photomicrograph illustrating NPY-immunoreactive fibers in the 
paraventricular nucleus (PVN; A) and arcuate nucleus (ARC; B).  Note the wing-shape 
distribution of fibers in the PVN, and the high density of fibers in the infundibular 
process of the ARC and ME.  VMH, ventromedial hypothalamus; pt, pars tuberalis of 
the adenohypophysis; 3v, third ventricle. Scale bars = 500 µm.   
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Density of NPY-immunoreactive fibers in the POA and hypothalamus 
The proportion of area covered by NPY immunoreactivity varied among the 
hypothalamic regions, but no significant differences among treatment groups were 
observed within any of the regions analyzed.  However, there was a trend for the 
proportion of area covered by NPY fibers to be greater in the PVN and ARC of lambs 
treated with leptin antagonist between birth and PD 14 than in control lambs and lambs 
treated with leptin antagonist between PD 30 and 35 (Table 2). 
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Table 2 
Mean proportion of area covered by NPY-immunoreactive fibers in the POA and 
hypothalamus of 40-day old male lambs (n = 4/group) treated with saline (CN), leptin 
antagonist between birth and PD 14 (EA), and leptin antagonist between PD 30 and 35 
(LA). 
 
  Treatment 
Area  Control  Early Antagonist  
Late 
Antagonist 
Arcuate nucleus 
 
 8.9+1.2  9.3+0.7  7.5+0.9 
Dorsomedial hypothalamus 
 
 3.1+0.3  2.3+0.4  2.2+0.1 
Lateral hypothalamus 
 
 1.0+0.2  1.2+0.2  0.8+0.1 
Median eminence 
 
 11.3+1.5  10.6+0.8  12.3+0.8 
Periventricular nucleus 
 
 4.4+0.8  3.5+0.5  3.0+0.3 
Premammillary ventral nucleus 
 
 5.5+0.6  4.0+1.1  4.1+0.4 
Preoptic area 
 
 5.4+0.8  5.6+0.7  4.6+0.5 
Paraventricular nucleus 
 
 5.7+0.9  8.0+1.2  5.6+0.4 
Ventromedial hypothalamus 
 
 3.2+0.2  3.0+0.3  2.5+0.3 
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CHAPTER IV 
DISCUSSION AND CONCLUSIONS 
The involvement of the leptin-NPY pathway on the control of food intake and energy 
expenditure has been well characterized [20].  In addition, a role for leptin on promoting 
neurite outgrowth in the hypothalamus during the infantile period in mice has been 
demonstrated [13].  In the current study, we investigated whether disruption of leptin 
signaling could influence development of NPY neuronal projections in the 
hypothalamus.  Although no effects of treatment with ovine leptin antagonist during the 
neonate and infantile periods were observed, there was a trend for increased density of 
NPY fibers in the PVN of lambs treated with leptin antagonist soon after birth.  This 
structural alteration may represent an important functional response of the hypothalamus 
to leptin insufficiency during the early postnatal period. 
 
Bouret et al. [13] demonstrated that hypothalamic explants collected from neonate mice 
and treated with leptin exhibited increased neurite outgrowth in the ARC compared to 
control explants.  A surge of leptin occurs during the early postnatal period in mice. 
Although it is unclear whether a consistent surge of leptin occurs in neonate/infantile 
lambs [17], it is believed that leptin is necessary during this period for appropriate 
development of neuronal projections that control metabolic functions.  Indeed, leptin 
treatment in leptin-deficient (ob/ob) mice restores the pattern of neuronal projections in 
the PVN [13].  In addition, these projections to the PVN contain agouti-related protein.  
Because agouti-related protein colocalizes with NPY in ARC neurons, it is predicted that 
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the increased density of agouti-related protein-containing projections in the PVN is 
resulted from an increased number of neuronal projections that originated from 
NPY/agouti-related protein neurons in the ARC.  Therefore, this observation indicates 
that leptin is necessary for normal development of neuronal projections from the ARC to 
the PVN. 
 
Injection of NPY directly into the PVN in rats increases food intake [8].  Because NPY 
receptors are linked to inhibition of cAMP formation via activation of the Gαi signaling 
pathway [21], it is plausible to suggest that NPY-inhibition of PVN neurons is involved 
in stimulation of food intake and decrease in energy expenditure.  Therefore, increased 
NPY fiber projection in PVN neurons may facilitate NPY inhibition of PVN neurons. 
This structural change in the hypothalamus may lead to increased feed consumption and 
weight gain, and decreased energy expenditure, later in life (juvenile/adulthood periods) 
when nutrient requirements for growth are diminished and food is abundant. Whether 
this structural-functional change leads to alterations in metabolism remains to be 
determined. 
 
The trend toward increased density of NPY fibers in the PVN of lambs treated with the 
leptin antagonist early during the neonate period may indicate a critical role for leptin on 
supporting neuronal development during this period.  In mice, ARC projections to the 
PVN, DMH and LH form during the first two weeks of life [22].  During this time, leptin 
does not have a significant effect on food intake, but it alters development of neuronal 
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projections in the hypothalamus [22]. The lack of differences in NPY fiber density in the 
PVN of lambs treated with leptin antagonist later during the infantile period (postnatal 
days 30 to 36) observed in the current study indicates that PVN projections are already 
established or less sensitive to perturbations in leptin signaling. 
 
In contrast to a previous study in which leptin deficiency in (ob/ob) mice is associated 
with reduction in fiber density in the PVN [13], we observed a trend toward increased 
NPY fiber density in PVN of lambs treated with leptin antagonist during the infantile 
period.  These contradictory observations may result from distinct temporal roles of 
leptin on development of hypothalamic functions.  In the ob/ob mouse model, leptin 
deficiency occurs during fetal and postnatal development.  Thus, mechanisms to 
compensate for the absence of leptin signaling may have occurred.  In our study in 
lambs, perturbation in leptin signaling was produced only during a short period after 
birth. 
 
With the exception of a trend for differences in NPY fibers in the PVN, no detectable 
changes in the density of NPY fibers were observed in any of the other regions 
investigated in this study.  We acknowledge that the procedure used in the current study 
to detect NPY fibers (immunocytochemistry) may have limited sensitivity in the 
detection of all components of NPY cells. For example, NPY soma in the ARC is 
difficult to detect by immunocytochemistry due to rapid axonal transport of vesicles 
containing the peptide.  Pretreatment with colchicine, a compound that arrests axonal 
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transport, improves detection of NPY-immunoreactivity in the soma of ARC neurons 
[23].  In addition, NPY gene expression, NPY synthesis and NPY release in those 
regions were not determined in our study.  Therefore, it is possible that disruption of 
leptin signaling as used in the current study may regulate distinct aspects of NPY neuron 
function not investigated in this study.  Moreover, only four lambs per group were used 
in the current study and inclusion of additional animals into each group is warranted to 
increase statistical power of analysis and for more appropriate conclusions.         
 
In conclusion, it is evident that both leptin and NPY interact for the development and 
organization of neuronal circuitries within the hypothalamus.  However, the results from 
this study indicate that short-term disruption of leptin signaling in infantile lambs does 
not clearly influence the density of NPY fibers in the hypothalamus.  Inclusion of 
additional animals in the study will increase the power for appropriate analysis.  In 
addition, further studies are needed to investigate if disruption of leptin signaling affects 
other biological functions of the NPY neuron. 
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